8-K: Solitron Devices Q3 Fiscal 2026: Sales, Bookings Surge

Solitron Devices, Inc. announced significant increases in net sales, bookings, and backlog for its fiscal 2026 third quarter.

Summary

• Net sales for the fiscal 2026 third quarter increased 49% to approximately $5.02 million, up from $3.37 million in the fiscal 2025 third quarter.
• Net bookings for the fiscal 2026 third quarter increased 73% to $13.91 million, compared to $8.05 million in the prior year third quarter.
• Backlog grew 124% to $27.48 million at the end of the fiscal 2026 third quarter, up from $12.28 million at the end of the fiscal 2025 third quarter.
• Net income for the fiscal 2026 third quarter was $0.65 million, or $0.31 per share, significantly higher than $0.27 million, or $0.13 per share, in the fiscal 2025 third quarter.
• For the nine months ended November 30, 2025, net sales increased 7% to approximately $11.71 million, compared to $10.92 million in the prior fiscal year period.
• Nine-month net bookings increased 78% to $21.03 million, up from $11.84 million in the prior fiscal year period.
• Net income for the nine months ended November 30, 2025, was $0.08 million, or $0.04 per share, a decrease from $0.87 million, or $0.42 per share, in the prior fiscal year period.
• The decrease in gross profit for the first nine months of fiscal 2026 was attributed to higher material costs and increased tariff costs, despite increased sales.
• Selling, general and administrative (SG&A) costs increased year-to-date primarily due to a one-time fully vested stock grant to the board and management, along with recurring quarterly options for the COO, totaling $344,000.
• The company received the expected AMRAAM Lot 39 order during the third quarter, which included greater quantities and higher pricing due to the expiration of a multi-year pricing agreement.
• Bookings for the quarter did not include any orders related to HIMARS or SM2/SM6.

Sentiment

Score: 7

Explanation: The company demonstrated strong operational performance in Q3 fiscal 2026 with significant increases in sales, bookings, and backlog, indicating robust demand in its core markets. The successful receipt of a key AMRAAM order and progress in new product development are positive. However, the substantial decline in nine-month net income due to higher material/tariff costs and increased SG&A from stock grants tempers the overall positive sentiment, highlighting cost management challenges.

Positives

• Net sales for Q3 fiscal 2026 increased significantly by 49% to $5.02 million.
• Net bookings for Q3 fiscal 2026 surged by 73% to $13.91 million.
• Backlog at the end of Q3 fiscal 2026 more than doubled, increasing 124% to $27.48 million.
• Net income for Q3 fiscal 2026 more than doubled to $0.65 million ($0.31 per share) from $0.27 million ($0.13 per share) in the prior year's third quarter.
• The company successfully received the expected AMRAAM Lot 39 order, which featured higher quantities and improved pricing.
• Increased interest in new product development and the creation of various prototypes for customer testing indicate potential future revenue sources.

Negatives

• Net income for the nine months ended November 30, 2025, significantly decreased to $0.08 million ($0.04 per share) from $0.87 million ($0.42 per share) in the prior fiscal year period.
• Gross profit decreased during the first nine months of fiscal 2026 despite increased sales, primarily due to higher material costs and increased tariff costs.
• Selling, general and administrative (SG&A) costs increased year-to-date for fiscal 2026, largely due to a $344,000 one-time fully vested stock grant to the board and management, and recurring quarterly options for the COO.
• Bookings for the quarter did not include any orders related to HIMARS or SM2/SM6.

Risks

• Potential adverse developments or changes in government budgetary spending and policy, including with respect to the war in Ukraine, which may lead to reduced government spending on programs in which the company participates.
• Inflation, elevated interest rates, adverse trends in the economy, and the possibility of a recession, which appears to have increased based on recent economic data.
• The possibility that management's estimates and assumptions regarding bookings, sales, and other metrics prove to be incorrect.
• Uncertainty regarding the timing and size of orders from clients, delivery schedules, and the company's liquidity and cash position.
• Challenges in the company's ability to make appropriate adjustments to its cost structure.
• Risks related to the company's ability to properly account for inventory in the future.
• Dependence on government contracts, which are subject to termination, price renegotiations, and regulatory compliance.
• The demand for the company's products and the potential loss of, or reduction of business from, substantial clients.
• Challenges in the company's ability to continue to integrate Micro Engineering Inc. (MEI) in an efficient and effective manner.
• The possibility that the MEI acquisition or any other acquisition or strategic transaction pursued by the company does not yield the desired or anticipated results or benefits.

Future Outlook

The company expects sales to reach a steadier level in the fiscal 2026 third and fourth quarters. Management is optimistic about creating additional revenue sources through increased interest in new product development and the ongoing testing of various prototypes by potential customers.

Management Comments

• Sales were expected to start to increase during fiscal second quarter, before reaching a steadier level in the fiscal 2026 third and fourth quarters.
• The expected AMRAAM Lot 39 order was received during our third quarter, along with other substantial customer orders.
• AMRAAM order quantities were greater than the prior year's order and included higher pricing due to the expiration of a multi-year pricing agreement.
• We continue to see increased interest in new product development and have developed various prototypes for testing by potential customers, remaining optimistic about creating additional revenue sources.

Industry Context

Solitron Devices operates in the specialized military and aerospace markets, providing solid-state semiconductor components. The strong growth in bookings and backlog, particularly with the receipt of the AMRAAM order, indicates robust demand within the defense sector, likely supported by ongoing government spending and geopolitical factors. The company's focus on custom-made products for the U.S. government aligns with the high-reliability and specific requirements of this industry.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess performance against global benchmarks.

Stakeholder Impact

• Shareholders: Strong Q3 performance in sales, bookings, and backlog could be positive, but the nine-month decline in net income and increased costs may raise concerns about profitability and efficiency.
• Employees: Continued growth and new product development efforts suggest stability and potential for future opportunities.
• Customers: Receipt of expected orders and focus on new product development indicate a commitment to meeting customer needs and innovation.
• Suppliers: Higher material costs suggest increased demand or pricing power from suppliers, potentially impacting the company's margins.

Next Steps

• Continue new product development and prototype testing for potential customers to create additional revenue sources.
• Manage cost structure effectively to mitigate impacts from higher material and tariff costs.
• Continue efficient and effective integration of Micro Engineering Inc. (MEI).

Key Dates

Recommendation

While Solitron Devices reported impressive Q3 fiscal 2026 growth in sales, bookings, and backlog, signaling strong operational momentum and demand in the military/aerospace sector, the nine-month financial performance shows a significant decline in net income due to higher material costs, tariffs, and increased SG&A from stock grants. The company successfully secured expected orders and is pursuing new product development, which are positive indicators. However, the persistent cost pressures and the overall nine-month profitability trend suggest a 'hold' position until there is clearer evidence of sustained profitability improvement and effective cost management, despite the strong top-line growth.

Keywords

Solitron Devices, SODI, semiconductor, military, aerospace, Q3 earnings, financial results, net sales, net bookings, backlog, net income, government contracts, AMRAAM, MEI acquisition, power transistors